Data and IP protection for pharma and biotech
Biotech and pharmaceutical firms must protect some of the most high-value data in the world, including research and clinical trial data, proprietary formulas, drug simulation models, and manufacturing processes as well as patient Protected Health Information (PHI).
Cyberhaven lets pharma and biotech firms protect all of these sensitive assets reliably and efficiently. Regulated data is automatically found and classified based on provenance and content. Every user data action is tracked, ensuring staff have a full auditable history of all critical data across networks, storage, and endpoints, or in the cloud.
Problems we solve
-
Automatically find your research data and PHI.
Proactively find all sensitive data whether it is structured PHI or unstructured trade secrets.
Cyberhaven finds copies of testing and research data even if you don’t know where to look.
Learn how it works -
Find risk and audit across the lifecycle of your data.
Track the who, how, and when of every data action to find risky users and actions before data is leaked. Are the latest clinical lab results being copy/pasted from a spreadsheet? Cyberhaven tells you.
Learn how it works -
Educate your staff without disrupting their work.
Protect data while keeping staff productive with flexible policies that go beyond simple block/allow options. Cyberhaven ensures your medical innovations remain protected but also arrive first to market.
Learn how it works
Sample data flow
The scenario
Alice, a staff researcher working on Phase III clinical trials of a COVID-19 vaccine, was approached through GLG by a business development manager working for a competitor, who offered a substantial amount of money for “just a copy.” Alice, buried in college debt, accepted. On her return to the lab, she found a file named export.csv on the lab’s shared Box folder that had been exported from the Medidata Rave EDC by research director Mike to run regression analysis. Alice copied export.csv to her desktop and saved it to a USB drive to give the competitor.
Cyberhaven solution
Cyberhaven detected exfiltration of clinical trials data to removable media. The data was traced when Mike exported it from Medidata Rave EDC and when Alice copied it to her desktop. When she saved the file to a USB drive, Cyberhaven knew the file contained clinical trial data from Medidata Rave EDC and raised an alert.